Medrhythms

Portland, ME · Founded 2013 · Privately Held (backing)

Provider of neurologic music therapy intended to offer evidence-based neurologic interventions to measure and improve walking. Medrhythms is based in Portland, ME and was founded in 2013. Its last reported valuation was $85 million in Jan 2024. It has raised $61.8 million across 7 recorded rounds; the latest was a $3.3 million seed round in Feb 2026.

Last reported valuation
$85.0M
Oct 2026
Priced at
—
Total raised
$61.8M
Last round
Seed Round
Feb 2026
What is Medrhythms worth?
$85.0Mlast reported valuation · Oct 2026

Medrhythms's last reported valuation, Jan 2024. Nothing priced has surfaced since.

Free account
More of Medrhythms with a free account
  • ·The complete investor list: 14 names
  • ·Watch Medrhythms: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Medrhythms funding history

7 rounds
DateRoundRaisedPost-money
Feb 2026Seed Round$3.3M▮
Mar 2025Seed Round$2.9M▮
Nov 2023Early Stage VC$19.8M▮
Feb 2023Early Stage VC$5.8M▮
Jul 2021Early Stage VC$20.9M▮
Aug 2019Seed Round$1.5M▮
+ 1 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Medrhythms valuation

Medrhythms's last reported valuation was $85 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Medrhythms raised?

Medrhythms has raised $61.8 million across 7 recorded rounds since 2018. The largest was a $5.8 million early-stage round in Feb 2023; the most recent was a $3.3 million seed round in Feb 2026.

Medrhythms has filed 7 Form Ds with the SEC since 2018, most recently in Apr 2025 ($2.9 million sold to 3 investors).

How Medrhythms's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Medrhythms, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Medrhythms

What is Medrhythms worth?
Medrhythms is valued at $85.0M as of Oct 2026. Medrhythms's last reported valuation, Jan 2024. Nothing priced has surfaced since.
How much has Medrhythms raised?
Medrhythms has raised $61.8M in total funding across 7 recorded rounds.
When did Medrhythms last raise?
Medrhythms last raised in Feb 2026 (Seed Round), raising $3.3M.